CSIMarket
 


Odonate Therapeutics Inc   (ODT)
Other Ticker:  
 

Odonate Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Odonate Therapeutics Inc in the third quarter 2021?
Odonate Therapeutics Inc recorded a cumulative net loss of $-102 million during 12 months ending in the third quarter 2021, resulting in a negative return on equity (ROE) of -102.72%.

Within the Major Pharmaceutical Preparations industry 315 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2021 from 0 to 3741.

What is ROE?



Return On Equity (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Equity Change -56.9 % -19.82 % -22.14 % -16.12 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -102 -119 -130 -126 -178
Return On Equity (TTM) -102.72 % -96.44 % -101.41 % -93.15 % -125.31 %
ODT's Total Ranking # 3741 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 71 85 105 136 166
Seq. Equity Change -15.66 % -19.64 % -22.66 % -17.79 % 56.9 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 316
Sector # 680
Overall # 3741

Return On Equity Statistics
High Average Low
65.67 %
-115.02 %
-305.58 %
(Sep 30 2016)   (Mar 31 2019)





ODT Annual Return On Equity (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
Total Equity in Millions 136 162 124 -2 0
Y / Y Equity Change -16.12 % 30.88 % - - -
Net Income in Millions -126 -112 -89 -2 -2
Y / Y Net Income Change - - - - -
Return On Equity -92.81 % -68.9 % -71.74 % - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ODT's' Return on Equity at Yahoo Finance
ODT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for ODT's Competitors
Return On Equity for Odonate Therapeutics Inc 's Suppliers
Roe for ODT's Customers




Companies with similar Return On Equity at Sep 30 2021, within Healthcare Sector ROE


Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com